(Q60187455)
Statements
Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment (English)
P Wipfler
K Oppermann
G Pilz
S Afazel
E Haschke-Becher
M Huemer
S Golaszewski
W Staffen
G Ladurner
11 October 2010